ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Schmidt Sells OMB On Training Grants, But Weinberger Is The One To Convince

December 21, 1973

ACS Research Grants Hit $78.2 Million

July 18, 1986

Cooperation Is ACS Theme For ‘90s; Dodd

February 1, 1991

NCI Communications Director Sieber To Retire; Science Planner Waldrop Also To Leave NCI.

September 14, 2001

NCI Program Develops Bioinformatics Tool To Design Cancer Drugs

September 13, 2002

Diet, Nutrition Committee To Rate Suggested Projects

January 9, 1976